Stratos Health has formed a strategic partnership with Superpower aimed at delivering preventive health and wellness solutions to employers and employees without direct expense. According to the company, the collaboration integrates Superpower’s diagnostics and personalized health planning into Stra…
In this thought leader piece Laurence Arnold, PhD, head of R&D at Pelago Bioscience, discusses prioritizing proof over progress, so decision-makers can fail faster–and smarter. Many failures were avoidable earlier. Hard-working teams just didn't have data that would let them make the call with …
Designs for Health has introduced Anaerostipes Probiotic, a dietary supplement featuring the next-generation strain Anaerostipes caccae CLB101™. This strain is known for its ability to directly produce butyrate, a short-chain fatty acid that supports gut barrier integrity and overall digestive healt…
Expanding from oncology into neurodegeneration, company leverages tiny extracellular vesicles to enhance blood-based biomarker discovery. Precision medicine biotech FYR Bio has closed an $8 million financing round to accelerate its expansion into neurodegenerative disease research, extending the com…
AbbVie has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration for tavapadon, a novel selective dopamine D1/D5 receptor partial agonist being studied as a once-daily oral treatment for Parkinson’s disease, according to the company. The submission is backed by data from the …
Sunrise has secured $29 million in a funding round led by Eurazeo, with contributions from investors including Amazon’s Alexa Fund and Kurma Partners, according to the company. The capital will be used to scale Dreem Health, its digital sleep clinic, expand clinical services, and build hardware and …
Advances in end-to-end multiomics platforms and the underlying scientific knowledge now enable faster and more precise biomarker discovery, mechanistic insight generation, and therapeutic design—core drivers of modern drug discovery programs. The post Multiomics Mass Spec Workflows in Drug Discovery…
Seoul — Sky Labs has launched CART BP, a ring-type personal blood pressure monitor designed for continuous 24-hour use, including during sleep, according to the company. Sky Labs said CART BP has been approved by South Korea’s Ministry of Food and Drug Safety (MFDS). It is built on technology from i…
Agency responds to petition by Natural Products Association and Alliance for Natural Health, allowing NMN as a dietary supplement. Once feted as a promising addition to the NAD+ supplement landscape, nicotinamide mononucleotide (NMN) found itself at the center of regulatory turbulence when the US Fo…
Biograph and Caristo Diagnostics announced the launch of what they describe as the first U.S. clinical study to explore AI-powered detection of coronary artery inflammation in asymptomatic patients, the companies said. The trial, open to Biograph’s high-tier “Black Tier” members who meet clinical el…
Alnylam has dosed the first patient in ZENITH, its global Phase 3 cardiovascular outcomes trial of the investigational therapy zilebesiran for patients with uncontrolled hypertension, the company said. The trial—which is being conducted in collaboration with Roche—will enroll about 11,000 patients a…
